메뉴 건너뛰기




Volumn 26, Issue 6, 2012, Pages 813-825

Drug interactions in palliative care-it's more than cytochrome P450

Author keywords

Analgesia; cytochrome p450 system; drug interactions; opioid analgesics; pain; palliative care

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYTOCHROME P450; DIURETIC AGENT; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; GLUCOCORTICOID; HISTAMINE; LEVOMETHADONE; METHADONE; METOCLOPRAMIDE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OPIATE AGONIST; PARTIAL AGONIST; POTASSIUM SALT; POTASSIUM SPARING DIURETIC AGENT; PROTEINASE INHIBITOR; PROTON PUMP INHIBITOR; PYRROLE DERIVATIVE; SCOPOLAMINE; SCOPOLAMINE BUTYL BROMIDE; UNINDEXED DRUG;

EID: 84859084506     PISSN: 02692163     EISSN: 1477030X     Source Type: Journal    
DOI: 10.1177/0269216311412231     Document Type: Article
Times cited : (24)

References (58)
  • 1
    • 70849137218 scopus 로고    scopus 로고
    • Drug interactions in oncology: How common are they?
    • Riechelmann RP, Del Giglio A. Drug interactions in oncology: how common are they?. Ann Oncol. 2009 ; 20: 1907-1912
    • (2009) Ann Oncol , vol.20 , pp. 1907-1912
    • Riechelmann, R.P.1    Del Giglio, A.2
  • 2
  • 3
    • 34247231457 scopus 로고    scopus 로고
    • Proposal for a new tool to evaluate drug interaction cases
    • Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007 ; 41: 674-680
    • (2007) Ann Pharmacother , vol.41 , pp. 674-680
    • Horn, J.R.1    Hansten, P.D.2    Chan, L.N.3
  • 4
    • 58149229547 scopus 로고    scopus 로고
    • Antiepileptic drugs in the treatment of neuropathic pain: Drug-to-drug interaction in elderly people
    • Lordos EF, Trombert V, Vogt N, Perrenoud JJ. Antiepileptic drugs in the treatment of neuropathic pain: drug-to-drug interaction in elderly people. J Am Geriatr Soc. 2009 ; 57: 181-182
    • (2009) J Am Geriatr Soc , vol.57 , pp. 181-182
    • Lordos, E.F.1    Trombert, V.2    Vogt, N.3    Perrenoud, J.J.4
  • 7
    • 2442433545 scopus 로고    scopus 로고
    • Clarifying adverse drug events: A clinician's guide to terminology, documentation, and reporting
    • Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med. 2004 ; 140: 795-801
    • (2004) Ann Intern Med , vol.140 , pp. 795-801
    • Nebeker, J.R.1    Barach, P.2    Samore, M.H.3
  • 8
    • 84865470107 scopus 로고    scopus 로고
    • New ABDA database classification of interactions showing the way through the interactions jungle
    • Zagermann-Muncke P. New ABDA database classification of interactions showing the way through the interactions jungle. PharmZtg. 2009 ; 2: 25-16
    • (2009) PharmZtg , vol.2 , pp. 25-16
    • Zagermann-Muncke, P.1
  • 9
    • 0008922584 scopus 로고    scopus 로고
    • (accessed January 2009 and October 2010)
    • Thomson Reuters. 'DRUGDEX System', http://www.micromedex.com/products/ drugdex/ (accessed January 2009 and October 2010).
    • Drugdex System
    • Thomson, R.1
  • 10
    • 0037380880 scopus 로고    scopus 로고
    • Histamine H1-receptor antagonists, promethazine and homochlorcyclizine, increase the steady-state plasma concentrations of haloperidol and reduced haloperidol
    • Suzuki A, Yasui-Furukori N, Mihara K, et al. Histamine H1-receptor antagonists, promethazine and homochlorcyclizine, increase the steady-state plasma concentrations of haloperidol and reduced haloperidol. Ther Drug Monit. 2003 ; 25: 192-196
    • (2003) Ther Drug Monit , vol.25 , pp. 192-196
    • Suzuki, A.1    Yasui-Furukori, N.2    Mihara, K.3
  • 12
    • 70450206025 scopus 로고    scopus 로고
    • Pharmacokinetic drug interactions in palliative care: Focus on opioids
    • Strouse TB. Pharmacokinetic drug interactions in palliative care: focus on opioids. J Palliat Med. 2009 ; 12: 1043-1050
    • (2009) J Palliat Med , vol.12 , pp. 1043-1050
    • Strouse, T.B.1
  • 13
    • 58149242547 scopus 로고    scopus 로고
    • Mechanism-based inhibition of cytochrome P450 enzymes: An evaluation of early decision making in vitro approaches and drug-drug interaction prediction methods
    • Grime KH, Bird J, Ferguson D, Riley RJ. Mechanism-based inhibition of cytochrome P450 enzymes: an evaluation of early decision making in vitro approaches and drug-drug interaction prediction methods. Eur J Pharm Sci. 2009 ; 36: 175-191
    • (2009) Eur J Pharm Sci , vol.36 , pp. 175-191
    • Grime, K.H.1    Bird, J.2    Ferguson, D.3    Riley, R.J.4
  • 14
    • 41549127146 scopus 로고    scopus 로고
    • Actual and potential drug interactions associated with methadone
    • Weschules DJ, Bain KT, Richeimer S. Actual and potential drug interactions associated with methadone. Pain Med. 2008 ; 9: 315-344
    • (2008) Pain Med , vol.9 , pp. 315-344
    • Weschules, D.J.1    Bain, K.T.2    Richeimer, S.3
  • 16
    • 34548443321 scopus 로고    scopus 로고
    • The use of opioid analgesia in end-stage renal disease patients managed without dialysis: Recommendations for practice
    • Murtagh FE, Chai MO, Donohoe P, Edmonds PM, Higginson IJ. The use of opioid analgesia in end-stage renal disease patients managed without dialysis: recommendations for practice. J Pain Palliat Care Pharmacother. 2007 ; 21: 5-16
    • (2007) J Pain Palliat Care Pharmacother , vol.21 , pp. 5-16
    • Murtagh, F.E.1    Chai, M.O.2    Donohoe, P.3    Edmonds, P.M.4    Higginson, I.J.5
  • 17
    • 77952228203 scopus 로고    scopus 로고
    • Implications of opioid analgesia for medically complicated patients
    • Smith H, Bruckenthal P. Implications of opioid analgesia for medically complicated patients. Drugs Aging. 2010 ; 27: 417-433
    • (2010) Drugs Aging , vol.27 , pp. 417-433
    • Smith, H.1    Bruckenthal, P.2
  • 19
    • 78649503393 scopus 로고    scopus 로고
    • Case report: Delirium due to a diltiazem-fentanyl CYP3A4 drug interaction
    • e649-648 e610
    • Levin TT, Bakr MH, Nikolova T. Case report: delirium due to a diltiazem-fentanyl CYP3A4 drug interaction. Gen Hosp Psychiatr. 2010 ; 32: 648 e649-648 e610
    • (2010) Gen Hosp Psychiatr , vol.32 , pp. 648
    • Levin, T.T.1    Bakr, M.H.2    Nikolova, T.3
  • 20
  • 21
    • 77954156991 scopus 로고    scopus 로고
    • Dihydrocodeine as an opioid analgesic for the treatment of moderate to severe chronic pain
    • Leppert W. Dihydrocodeine as an opioid analgesic for the treatment of moderate to severe chronic pain. Curr Drug Metab. 2010 ; 11: 494-506
    • (2010) Curr Drug Metab , vol.11 , pp. 494-506
    • Leppert, W.1
  • 22
    • 0031839871 scopus 로고    scopus 로고
    • The visceral and somatic antinociceptive effects of dihydrocodeine and its metabolite, dihydromorphine. A cross-over study with extensive and quinidine-induced poor metabolizers
    • Wilder-Smith CH, Hufschmid E, Thormann W. The visceral and somatic antinociceptive effects of dihydrocodeine and its metabolite, dihydromorphine. A cross-over study with extensive and quinidine-induced poor metabolizers. Br J Clin Pharmacol. 1998 ; 45: 575-581
    • (1998) Br J Clin Pharmacol , vol.45 , pp. 575-581
    • Wilder-Smith, C.H.1    Hufschmid, E.2    Thormann, W.3
  • 23
    • 0031441325 scopus 로고    scopus 로고
    • Drug interaction potential of fluoxetine, sertraline, and paroxetine in four state psychiatric hospital populations
    • Markowitz JS, Devine CL. Drug interaction potential of fluoxetine, sertraline, and paroxetine in four state psychiatric hospital populations. Ther Drug Monit. 1997 ; 19: 244-245
    • (1997) Ther Drug Monit , vol.19 , pp. 244-245
    • Markowitz, J.S.1    Devine, C.L.2
  • 24
    • 67649133619 scopus 로고    scopus 로고
    • Over-the-counter medications and cancer patients: Growing awareness of drug-drug interactions
    • Hanigan MH. Over-the-counter medications and cancer patients: growing awareness of drug-drug interactions. Expert Opin Drug Metab Toxicol. 2009 ; 5: 105-107
    • (2009) Expert Opin Drug Metab Toxicol , vol.5 , pp. 105-107
    • Hanigan, M.H.1
  • 25
    • 73349121627 scopus 로고    scopus 로고
    • Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study
    • Kobata Y, Yajima H, Yamao J, Tanaka Y, Fukui H, Takakura Y. Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study. Mod Rheumatol. 2009 ; 19: 629-636
    • (2009) Mod Rheumatol , vol.19 , pp. 629-636
    • Kobata, Y.1    Yajima, H.2    Yamao, J.3    Tanaka, Y.4    Fukui, H.5    Takakura, Y.6
  • 26
    • 78650630989 scopus 로고    scopus 로고
    • Adverse drug reactions and drug interactions in analgesic therapy
    • Bertsche T, Mikus G. Adverse drug reactions and drug interactions in analgesic therapy. Ther Umsch. 2011 ; 68: 19-26
    • (2011) Ther Umsch , vol.68 , pp. 19-26
    • Bertsche, T.1    Mikus, G.2
  • 27
    • 33947596046 scopus 로고    scopus 로고
    • Update on the role of non-opioids for postoperative pain treatment
    • Schug SA, Manopas A. Update on the role of non-opioids for postoperative pain treatment. Best Pract Res Clin Anaesthesiol. 2007 ; 21: 15-30
    • (2007) Best Pract Res Clin Anaesthesiol , vol.21 , pp. 15-30
    • Schug, S.A.1    Manopas, A.2
  • 28
    • 0036271240 scopus 로고    scopus 로고
    • Effects of dipyrone on inflammatory infiltration and oxidative metabolism in gastric mucosa: Comparison with acetaminophen and diclofenac
    • Sanchez S, Martin MJ, Ortiz P, Motilva V, Alarcon de la Lastra C. Effects of dipyrone on inflammatory infiltration and oxidative metabolism in gastric mucosa: comparison with acetaminophen and diclofenac. Dig Dis Sci. 2002 ; 47: 1389-1398
    • (2002) Dig Dis Sci , vol.47 , pp. 1389-1398
    • Sanchez, S.1    Martin, M.J.2    Ortiz, P.3    Motilva, V.4    Alarcon De La Lastra, C.5
  • 29
    • 42649093814 scopus 로고    scopus 로고
    • Potential drug interactions in cancer patients receiving supportive care exclusively
    • RiechelmannRPZimmermannCChinSN. Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage2008; 35: 535-543.
    • (2008) J Pain Symptom Manage , vol.35 , pp. 535-543
    • Riechelmann, R.P.1    Zimmermann, C.2    Chin, S.N.3
  • 30
    • 33745315683 scopus 로고    scopus 로고
    • Update on guidelines for the treatment of chronic musculoskeletal pain
    • Schnitzer TJ. Update on guidelines for the treatment of chronic musculoskeletal pain. Clin Rheumatol. 2006 ; 25 (Suppl 1). S22-29
    • (2006) Clin Rheumatol , vol.25 , Issue.SUPPL. 1 , pp. 22-29
    • Schnitzer, T.J.1
  • 31
    • 0027456560 scopus 로고
    • Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states
    • Friedel HA, Fitton A. Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states. Drugs. 1993 ; 45: 548-569
    • (1993) Drugs , vol.45 , pp. 548-569
    • Friedel, H.A.1    Fitton, A.2
  • 32
    • 84865451146 scopus 로고    scopus 로고
    • Flupirtine is a safe alternative drug in patients with hypersensitivity to NSAIDs
    • (accessed 4 April 2011)
    • TreudlerRPohleKSimonJC. Flupirtine is a safe alternative drug in patients with hypersensitivity to NSAIDs. Eur J Clin Pharmacol2011; 00: 1-3 (accessed 4 April 2011).
    • (2011) Eur J Clin Pharmacol , vol.0 , pp. 1-3
    • Treudler, R.1    Pohle, K.2    Simon, J.C.3
  • 33
    • 0000195185 scopus 로고    scopus 로고
    • The 20 essential drugs in palliative care
    • Dickerson D. The 20 essential drugs in palliative care. Eur J Palliat Care. 1999 ; 6: 130-135
    • (1999) Eur J Palliat Care , vol.6 , pp. 130-135
    • Dickerson, D.1
  • 34
    • 77949470479 scopus 로고    scopus 로고
    • Management of refractory breathlessness in patients with advanced cancer
    • Simon ST, Bausewein C. Management of refractory breathlessness in patients with advanced cancer. Wien Med Wochenschr. 2009 ; 159: 591-598
    • (2009) Wien Med Wochenschr , vol.159 , pp. 591-598
    • Simon, S.T.1    Bausewein, C.2
  • 35
    • 68849089462 scopus 로고    scopus 로고
    • Comparative tolerability of newer agents for insomnia
    • Zammit G. Comparative tolerability of newer agents for insomnia. Drug Saf. 2009 ; 32: 735-748
    • (2009) Drug Saf , vol.32 , pp. 735-748
    • Zammit, G.1
  • 36
    • 0023902538 scopus 로고
    • A sleep laboratory evaluation of the long-term efficacy of zopiclone
    • Fleming JA, Bourgouin J, Hamilton P. A sleep laboratory evaluation of the long-term efficacy of zopiclone. Can J Psychiatr. 1988 ; 33: 103-107
    • (1988) Can J Psychiatr , vol.33 , pp. 103-107
    • Fleming, J.A.1    Bourgouin, J.2    Hamilton, P.3
  • 37
    • 33749353523 scopus 로고    scopus 로고
    • Pharmacokinetic interaction between fluoxetine and metoclopramide in healthy volunteers
    • Vlase L, Leucuta A, Farcau D, Nanulescu M. Pharmacokinetic interaction between fluoxetine and metoclopramide in healthy volunteers. Biopharm Drug Dispos. 2006 ; 27: 285-289
    • (2006) Biopharm Drug Dispos , vol.27 , pp. 285-289
    • Vlase, L.1    Leucuta, A.2    Farcau, D.3    Nanulescu, M.4
  • 38
    • 61349192144 scopus 로고    scopus 로고
    • Influence of domperidone on pharmacokinetics, safety and tolerability of the dopamine agonist rotigotine
    • Braun M, Cawello W, Boekens H, Horstmann R. Influence of domperidone on pharmacokinetics, safety and tolerability of the dopamine agonist rotigotine. Br J Clin Pharmacol. 2009 ; 67: 209-215
    • (2009) Br J Clin Pharmacol , vol.67 , pp. 209-215
    • Braun, M.1    Cawello, W.2    Boekens, H.3    Horstmann, R.4
  • 39
    • 0019917839 scopus 로고
    • Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic
    • Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS. Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic. Drugs. 1982 ; 24: 360-400
    • (1982) Drugs , vol.24 , pp. 360-400
    • Brogden, R.N.1    Carmine, A.A.2    Heel, R.C.3    Speight, T.M.4    Avery, G.S.5
  • 40
    • 27744576368 scopus 로고    scopus 로고
    • Antidepressant drug-drug interaction profile update
    • Ereshefsky L, Jhee S, Grothe D. Antidepressant drug-drug interaction profile update. Drugs R D. 2005 ; 6: 323-336
    • (2005) Drugs R D , vol.6 , pp. 323-336
    • Ereshefsky, L.1    Jhee, S.2    Grothe, D.3
  • 41
    • 48549093980 scopus 로고    scopus 로고
    • Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update
    • Spina E, Santoro V, D'Arrigo C. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Clin Ther. 2008 ; 30: 1206-1227
    • (2008) Clin Ther , vol.30 , pp. 1206-1227
    • Spina, E.1    Santoro, V.2    D'Arrigo, C.3
  • 42
    • 0033810675 scopus 로고    scopus 로고
    • Metabolism of the antidepressant mirtazapine in vitro: Contribution of cytochromes P-450 1A2, 2D6, and 3A4
    • Stormer E, von Moltke LL, Shader RI, Greenblatt DJ. Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4. Drug Metab Dispos. 2000 ; 28: 1168-1175
    • (2000) Drug Metab Dispos , vol.28 , pp. 1168-1175
    • Stormer, E.1    Von Moltke, L.L.2    Shader, R.I.3    Greenblatt, D.J.4
  • 43
    • 79551555754 scopus 로고    scopus 로고
    • Current concepts in the management of opioid-induced constipation
    • Walters JB, Montagnini M. Current concepts in the management of opioid-induced constipation. J Opioid Manag. 2010 ; 6: 435-444
    • (2010) J Opioid Manag , vol.6 , pp. 435-444
    • Walters, J.B.1    Montagnini, M.2
  • 44
    • 77958484639 scopus 로고    scopus 로고
    • NSAID-induced gastrointestinal and cardiovascular injury
    • Ng SC, Chan FK. NSAID-induced gastrointestinal and cardiovascular injury. Curr Opin Gastroenterol. 2010 ; 26: 611-617
    • (2010) Curr Opin Gastroenterol , vol.26 , pp. 611-617
    • Ng, S.C.1    Chan, F.K.2
  • 45
    • 0028582182 scopus 로고
    • Steroids and peptic ulcer: An end to the controversy?
    • Gotzsche PC. Steroids and peptic ulcer: an end to the controversy?. J Intern Med. 1994 ; 236: 599-601
    • (1994) J Intern Med , vol.236 , pp. 599-601
    • Gotzsche, P.C.1
  • 46
    • 1542540024 scopus 로고    scopus 로고
    • Management of intractable, cirrhotic ascites with an indwelling drainage catheter
    • Reisfield GM, Wilson GR. Management of intractable, cirrhotic ascites with an indwelling drainage catheter. J Palliat Med. 2003 ; 6: 787-791
    • (2003) J Palliat Med , vol.6 , pp. 787-791
    • Reisfield, G.M.1    Wilson, G.R.2
  • 47
    • 70449706438 scopus 로고    scopus 로고
    • A comprehensive review of the loop diuretics: Should furosemide be first line?
    • Wargo KA, Banta WM. A comprehensive review of the loop diuretics: should furosemide be first line?. Ann Pharmacother. 2009 ; 43: 1836-1847
    • (2009) Ann Pharmacother , vol.43 , pp. 1836-1847
    • Wargo, K.A.1    Banta, W.M.2
  • 48
    • 68349111750 scopus 로고    scopus 로고
    • Provision of palliative care for chronic heart failure inpatients: How much do we need?
    • Harding R, Beynon T, Hodson F, et al. Provision of palliative care for chronic heart failure inpatients: how much do we need?. BMC Palliat Care. 2009 ; 8: 8
    • (2009) BMC Palliat Care , vol.8 , pp. 8
    • Harding, R.1    Beynon, T.2    Hodson, F.3
  • 49
    • 66249108231 scopus 로고    scopus 로고
    • Palliative care in heart failure: A position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology
    • Jaarsma T, Beattie JM, Ryder M, et al. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009 ; 11: 433-443
    • (2009) Eur J Heart Fail , vol.11 , pp. 433-443
    • Jaarsma, T.1    Beattie, J.M.2    Ryder, M.3
  • 50
    • 0025731996 scopus 로고
    • Antidepressant treatment and side effect considerations
    • Tollefson GD. Antidepressant treatment and side effect considerations. J Clin Psychiatry. 1991 ; 52: 4-13
    • (1991) J Clin Psychiatry , vol.52 , pp. 4-13
    • Tollefson, G.D.1
  • 51
    • 44949197754 scopus 로고    scopus 로고
    • Interventions for noisy breathing in patients near to death
    • Wee B, Hillier R. Interventions for noisy breathing in patients near to death. Cochrane Database Syst Rev. 2008 ;: CD005177
    • (2008) Cochrane Database Syst Rev , pp. 005177
    • Wee, B.1    Hillier, R.2
  • 52
    • 42649119796 scopus 로고    scopus 로고
    • Death rattle: Its impact on staff and volunteers in palliative care
    • Wee B, Coleman P, Hillier R, Holgate S. Death rattle: its impact on staff and volunteers in palliative care. Palliat Med. 2008 ; 22: 173-176
    • (2008) Palliat Med , vol.22 , pp. 173-176
    • Wee, B.1    Coleman, P.2    Hillier, R.3    Holgate, S.4
  • 53
    • 33644909875 scopus 로고    scopus 로고
    • Clinically relevant drug interactions with antiepileptic drugs
    • Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol. 2006 ; 61: 246-255
    • (2006) Br J Clin Pharmacol , vol.61 , pp. 246-255
    • Perucca, E.1
  • 54
    • 0030925252 scopus 로고    scopus 로고
    • In vivo induction and in vitro inhibition of hepatic cytochrome P450 activity by the benzodiazepine anticonvulsants clonazepam and diazepam
    • Nims RW, Prough RA, Jones CR, et al. In vivo induction and in vitro inhibition of hepatic cytochrome P450 activity by the benzodiazepine anticonvulsants clonazepam and diazepam. Drug Metab Dispos. 1997 ; 25: 750-756
    • (1997) Drug Metab Dispos , vol.25 , pp. 750-756
    • Nims, R.W.1    Prough, R.A.2    Jones, C.R.3
  • 55
    • 0030339215 scopus 로고    scopus 로고
    • Use-dependent regulation of GABAA receptors
    • Barnes EM. Use-dependent regulation of GABAA receptors. Int Rev Neurobiol. 1996 ; 39: 53-76
    • (1996) Int Rev Neurobiol , vol.39 , pp. 53-76
    • Barnes, E.M.1
  • 56
    • 60349092371 scopus 로고    scopus 로고
    • Pharmacodynamic and pharmacokinetic interaction profiles of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: An isobolographic analysis
    • Dudra-Jastrzebska M, Andres-Mach MM, Sielski M, et al. Pharmacodynamic and pharmacokinetic interaction profiles of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis. Eur J Pharmacol. 2009 ; 605: 87-94
    • (2009) Eur J Pharmacol , vol.605 , pp. 87-94
    • Dudra-Jastrzebska, M.1    Andres-Mach, M.M.2    Sielski, M.3
  • 57
    • 64849092311 scopus 로고    scopus 로고
    • Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: A randomized, double-blind, four-arm trial in adults undergoing abdominal surgery
    • Oifa S, Sydoruk T, White I, et al. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery. Clin Ther. 2009 ; 31: 527-541
    • (2009) Clin Ther , vol.31 , pp. 527-541
    • Oifa, S.1    Sydoruk, T.2    White, I.3
  • 58
    • 45549095381 scopus 로고    scopus 로고
    • Caring for the treatment-experienced breast cancer patient: The pharmacist's role
    • Barbour SY. Caring for the treatment-experienced breast cancer patient: the pharmacist's role. Am J Health Syst Pharm. 2008 ; 65: S16-22
    • (2008) Am J Health Syst Pharm , vol.65 , pp. 16-22
    • Barbour, S.Y.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.